Skip Navigation

George P. Canellos, MD


Medical Oncology

Make an Appointment
Watch Video

Physician

  • Institute Physician
  • William Rosenberg Professor of Medicine, Harvard Medical School

Centers/Programs

Clinical Interests

  • Chronic lymphocytic leukemia
  • Lymphoma

Diseases Treated

  • Lymphoma, Hodgkin
  • Lymphoma, Non-Hodgkin

Contact Information

  • Appointments617-632-6246 (new)
    617-632-3470 (follow-up)
  • Office Phone Number617-632-3470
  • Fax617-632-3477

Bio

Dr. Canellos received his MD in 1960 from Columbia University. After internship and residency at Massachusetts General Hospital, he was a clinical associate at the National Cancer Institute and a research fellow at the Royal Postgraduate Medical School in London. From 1975 to 1995, he served as chief of DFCI's Division of Medical Oncology and as medical director for network development for Dana-Farber/Partners CancerCare. He is currently a senior physician at DFCI and Brigham and Women's Hospital. He is the former Editor-in-Chief of the Journal of Clinical Oncology and President of the American Society of Clinical Oncology.

Board Certification:

  • Hematology, 1972
  • Internal Medicine, 1967
  • Medical Oncology, 1973

Fellowship:

  • Massachusetts General Hospital, Medicine
  • National Cancer Institute, Medicine

Residency:

  • Massachusetts General Hospital, Internal Medicine

Medical School:

  • Columbia University College of Physicians & Surgeons

Recent Awards:

  • Honorary Doctor of Science, University of Athens, Greece 1997
  • Key to the Cure Award, The Cure for Lymphoma Foundation 1999
  • Distinguished Service Award for Scientific Achievement, American Society of Clinical Oncology 1996
  • San Salvatore Foundation Award at the 9th International Conference on Lymphoma. 2005
  • Karl Musshof Award from the 7th International Hodgkin Lymphoma Symposium 2007
  • Frank S. Moran Clinical Research Award, University of Michigan Cancer Center 2006
  • Fellowship, Royal College of Physicians London and Edinburgh 1991
  • Ellis Island Foundation Medal of Honor 2004
  • Statesman Award, American Society of Clinical Oncology 2007

Research

Diagnosis and Treatment of Lymphoma

Our research interests span a broad area of cytotoxic chemotherapeutic agents as well as biological agents for the treatment of malignant diseases. As former chair of the Lymphoma Committee of the Cancer and Leukemia Group B, a national cooperative trials group, Dr. Canellos initiated clinical trials in close collaboration with other groups. These trials search for answers concerning many issues, such as: -The optimal tolerable chemotherapy regimen for the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma- The integration of antibody therapy with cytotoxic agents for the treatment of these diseases- The role of early high-dose autologous transplantation in the management of poor-prognosis patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.In addition, new initiatives are under way in the use of radioimmunotherapy combined with cytotoxic therapy and the development of new agents for the treatment of lymphoma. We are exploring diagnostics to define the presence of residual disease using positron emission tomographic (PET) scans and a comparison with gallium/single photon emission computed tomography. SPECT was pioneered at DFCI for the treatment of lymphoma, and has helped to identify those patients at particularly high risk following cytotoxic treatment.He continues to be the "senior statesman" in the lymphoma group.

Canellos GP, LaCasce AS. Brentuximab Vedotin for Stage III or IV Hodgkin’s Lymphoma. N Engl J Med. 2018 04 19; 378(16):1560.
View in: PubMed

DeVita VT, Canellos GP. Combination chemotherapy of solid tumors: an American-Italian collaboration: a celebration of the work of Gianni Bonadonna. Tumori. 2016 Mar-Apr; 102(2):124-6.
View in: PubMed

Canellos G, Devita V. Gianni Bonadonna (1934-2015). Leuk Lymphoma. 2016; 57(4):739.
View in: PubMed

Canellos G, DeVita V. Gianni Bonadonna: A Personal Remembrance. Oncologist. 2015 Nov; 20(11):1348-9.
View in: PubMed

Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000.
View in: PubMed

Canellos GP. Advanced DLBCL: as systemic therapy improves, the need for RT diminishes. Oncology (Williston Park). 2014 Dec; 28(12):1085-6.
View in: PubMed

Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, Devita VT. Treatment of Hodgkin lymphoma: a 50-year perspective. J Clin Oncol. 2014 Jan 20; 32(3):163-8.
View in: PubMed

Canellos GP. Treatment for favorable localized Hodgkin lymphoma: the final answer is awaited. Oncology (Williston Park). 2012 Dec; 26(12):1199-200, 1202.
View in: PubMed

Kostakoglu L, Schöder H, Johnson JL, Hall NC, Schwartz LH, Straus DJ, LaCasce AS, Jung SH, Bartlett NL, Canellos GP, Cheson BD. Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone? Leuk Lymphoma. 2012 Nov; 53(11):2143-50.
View in: PubMed

Canellos GP. Brentuximab vedotin and panobinostat: new drugs for Hodgkin's lymphoma--can they make one of medical oncology's chemotherapy success stories more successful? J Clin Oncol. 2012 Jun 20; 30(18):2171-2.
View in: PubMed

Wilson WH, Jung SH, Porcu P, Hurd D, Johnson J, Martin SE, Czuczman M, Lai R, Said J, Chadburn A, Jones D, Dunleavy K, Canellos G, Zelenetz AD, Cheson BD, Hsi ED. A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica. 2012 May; 97(5):758-65.
View in: PubMed

Cote GM, Canellos GP. Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy? Curr Hematol Malig Rep. 2011 Sep; 6(3):180-6.
View in: PubMed

Straus DJ, Johnson JL, LaCasce AS, Bartlett NL, Kostakoglu L, Hsi ED, Schöder H, Hall NC, Jung SH, Canellos GP, Schwartz LH, Takvorian RW, Juweid ME, Cheson BD. Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood. 2011 May 19; 117(20):5314-20.
View in: PubMed

DeVita VT, Canellos GP. Hematology in 2010: New therapies and standard of care in oncology. Nat Rev Clin Oncol. 2011 Feb; 8(2):67-8.
View in: PubMed

Barnes JA, LaCasce AS, Zukotynski K, Israel D, Feng Y, Neuberg D, Toomey CE, Hochberg EP, Canellos GP, Abramson JS. End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma. Ann Oncol. 2011 Apr; 22(4):910-5.
View in: PubMed

Canellos GP, Abramson JS, Fisher DC, LaCasce AS. Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy. J Clin Oncol. 2010 Mar 20; 28(9):1611-5.
View in: PubMed

Canellos GP. Is chemotherapy alone for early Hodgkin lymphoma an emerging therapeutic option? Oncologist. 2009 Dec; 14(12):1167-8.
View in: PubMed

Canellos GP, Niedzwiecki D, Johnson JL. Long-term follow-up of survival in Hodgkin's lymphoma. N Engl J Med. 2009 Dec 10; 361(24):2390-1.
View in: PubMed

Canellos GP, Mauch P. What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma? J Clin Oncol. 2010 Jan 01; 28(1):e8.
View in: PubMed

Damon LE, Johnson JL, Niedzwiecki D, Cheson BD, Hurd DD, Bartlett NL, Lacasce AS, Blum KA, Byrd JC, Kelly M, Stock W, Linker CA, Canellos GP. Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909. J Clin Oncol. 2009 Dec 20; 27(36):6101-8.
View in: PubMed

Smith SM, Johnson J, Cheson BD, Canellos G, Petroni G, Oken M, Duggan D, Hurd D, Gockerman JP, Parker B, Prchal J, Peterson BA. Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691. Leuk Lymphoma. 2009 Oct; 50(10):1606-17.
View in: PubMed

Armand P, Gannamaneni S, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, LaCasce AS, Jacobsen ED, Fisher DC, Brown JR, Canellos GP, Freedman AS, Soiffer RJ, Antin JH. Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning. J Clin Oncol. 2008 Dec 10; 26(35):5767-74.
View in: PubMed

Canellos GP. What constitutes "improved prognosis"? J Clin Oncol. 2008 Apr 20; 26(12):1913-4.
View in: PubMed

Armand P, Kim HT, Ho VT, Cutler CS, Koreth J, Antin JH, LaCasce AS, Jacobsen ED, Fisher DC, Brown JR, Canellos GP, Freedman AS, Soiffer RJ, Alyea EP. Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome. Biol Blood Marrow Transplant. 2008 Apr; 14(4):418-25.
View in: PubMed

Canellos GP. Relapsed and refractory Hodgkin's lymphoma: new avenues? Hematol Oncol Clin North Am. 2007 Oct; 21(5):929-41.
View in: PubMed

Blum KA, Johnson JL, Niedzwiecki D, Canellos GP, Cheson BD, Bartlett NL. Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206. Leuk Lymphoma. 2007 Jul; 48(7):1313-9.
View in: PubMed

Peterson BA, Johnson J, Shipp MA, Barcos M, Gockerman JP, Canellos GP. High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351. Leuk Lymphoma. 2007 May; 48(5):870-80.
View in: PubMed

Bartlett NL, Niedzwiecki D, Johnson JL, Friedberg JW, Johnson KB, van Besien K, Zelenetz AD, Cheson BD, Canellos GP. Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Ann Oncol. 2007 Jun; 18(6):1071-9.
View in: PubMed

Czuczman MS, Porcu P, Johnson J, Niedzwiecki D, Kelly M, Hsi ED, Cook JR, Canellos G, Cheson BD. Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901. Leuk Lymphoma. 2007 Jan; 48(1):97-103.
View in: PubMed

Smith SM, Johnson JL, Niedzwiecki D, Eder JP, Canellos G, Cheson BD, Bartlett NL. Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906. Leuk Lymphoma. 2006 Aug; 47(8):1511-7.
View in: PubMed

Krueger G, Canellos G. Where does hematology end and oncology begin? Questions of professional boundaries and medical authority. J Clin Oncol. 2006 Jun 01; 24(16):2583-8.
View in: PubMed

Cheson BD, Canellos GP. The cancer and leukemia group B lymphoma committee. Clin Cancer Res. 2006 Jun 01; 12(11 Pt 2):3572s-5s.
View in: PubMed

Canellos GP. Introduction to a special series of unique entities within the spectrum of large-cell lymphoma. Oncologist. 2006 Apr; 11(4):374.
View in: PubMed

Canellos GP. Clinical trials in North America. Eur J Haematol Suppl. 2005 Jul; (66):121-4.
View in: PubMed

Wilson WH, Porcu P, Hurd D, Martin SE, Czuczman M, Niedzwiecki D, Saint Louis JD, Johnson JL, Cheson B, Canellos GP, Zelenetz AD. Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103. J Clin Oncol. 2005 Jun; 23(16_suppl):6530.
View in: PubMed

Canellos GP. Chemotherapy alone for early Hodgkin's lymphoma: an emerging option. J Clin Oncol. 2005 Jul 20; 23(21):4574-6.
View in: PubMed

Canellos GP. Lymphoma: present and future challenges. Semin Hematol. 2004 Oct; 41(4 Suppl 7):26-31.
View in: PubMed

Canellos GP, Duggan D, Johnson J, Niedzwiecki D. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen? J Clin Oncol. 2004 Apr 15; 22(8):1532-3.
View in: PubMed

Rizzieri DA, Johnson JL, Niedzwiecki D, Lee EJ, Vardiman JW, Powell BL, Barcos M, Bloomfield CD, Schiffer CA, Peterson BA, Canellos GP, Larson RA. Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251. Cancer. 2004 Apr 01; 100(7):1438-48.
View in: PubMed

Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. Leuk Lymphoma. 2004 Jan; 45(1):85-92.
View in: PubMed

Friedberg JW, Neuberg D, Kim H, Miyata S, McCauley M, Fisher DC, Takvorian T, Canellos GP. Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity. Cancer. 2003 Sep 01; 98(5):978-82.
View in: PubMed

Canellos G. Prognostic factors in large-cell lymphoma. Clin Adv Hematol Oncol. 2003 May; 1(5):269-70.
View in: PubMed

Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Peterson BA. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol. 2003 Feb 15; 21(4):607-14.
View in: PubMed

Canellos GP, Gollub J, Neuberg D, Mauch P, Shulman LN. Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up. Ann Oncol. 2003 Feb; 14(2):268-72.
View in: PubMed

Canellos GP, Niedzwiecki D. Long-term follow-up of Hodgkin's disease trial. N Engl J Med. 2002 May 02; 346(18):1417-8.
View in: PubMed

Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, Tarbell NJ, Friedberg J, Canellos GP, Mauch PM. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol. 2002 Apr 15; 20(8):2101-8.
View in: PubMed

Canellos GP. New treatments for advanced Hodgkin's disease: an uphill fight beginning close to the top. J Clin Oncol. 2002 Feb 01; 20(3):607-9.
View in: PubMed

Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP. Lymphomas of the breast: primary and secondary involvement. Cancer. 2002 Jan 01; 94(1):6-13.
View in: PubMed

Canellos GP. Primary treatment of Hodgkin's disease. Ann Oncol. 2002; 13 Suppl 4:153-8.
View in: PubMed

Johnson EA, Klimstra DS, Herndon JE, Catalano E, Canellos GP, Graziano SL, Kern JA, Green MR. Aberrant p53 staining does not predict cisplatin resistance in locally advanced non-small cell lung cancer. Cancer Invest. 2002; 20(5-6):686-92.
View in: PubMed

Josting A, Engert A, Diehl V, Canellos GP. Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease. Ann Oncol. 2002; 13 Suppl 1:112-6.
View in: PubMed

Bartlett NL, Petroni GR, Parker BA, Wagner ND, Gockerman JP, Omura GA, Canellos GP, Robert M, Johnson JL, Peterson BA. Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854. Cancer. 2001 Jul 15; 92(2):207-17.
View in: PubMed

Cameron CL, Cella D, Herndon JE, Kornblith AB, Zuckerman E, Henderson E, Weiss RB, Cooper MR, Silver RT, Leone L, Canellos GP, Peterson BA, Holland JC. Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning. Health Psychol. 2001 Jan; 20(1):71-5.
View in: PubMed

Penson RT, Dignan FL, Canellos GP, Picard CL, Lynch TJ. Burnout: caring for the caregivers. Oncologist. 2000; 5(5):425-34.
View in: PubMed

Loprinzi CL, Canellos GP. A new addition to the Journal of Clinical Oncology: the art of oncology--when the tumor is not the target. J Clin Oncol. 2000 Jan; 18(1):3.
View in: PubMed

Wasserman TH, Petroni GR, Millard FE, Chung CT, Barcos M, Johnson JL, Canellos GP, Peterson BA. Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features: A phase II Cancer and Leukemia Group B Study (9051). Cancer. 1999 Oct 15; 86(8):1590-5.
View in: PubMed

DeVita VT, Canellos GP. The lymphomas. Semin Hematol. 1999 Oct; 36(4 Suppl 7):84-94.
View in: PubMed

Canellos GP. Clinical research saves money: reflections on high-dose therapy of breast cancer. J Clin Oncol. 1999 Jul; 17(7):1965-6.
View in: PubMed

Levine EG, Cirrincione CT, Szatrowski TP, Canellos G, Norton L, Henderson IC. Phase II trial of topotecan in advanced breast cancer: a Cancer and Leukemia Group B study. Am J Clin Oncol. 1999 Jun; 22(3):218-22.
View in: PubMed

Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-López A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999 Apr; 17(4):1244.
View in: PubMed

Smith D, Shaffer K, Kirn D, Canellos GP, Mauch PM, Shulman LN. Mediastinal large cell lymphoma: prognostic significance of CT findings at presentation and after treatment. Oncology. 1998 Jul-Aug; 55(4):284-8.
View in: PubMed

Kornblith AB, Herndon JE, Zuckerman E, Cella DF, Cherin E, Wolchok S, Weiss RB, Diehl LF, Henderson E, Cooper MR, Schiffer C, Canellos GP, Mayer RJ, Silver RT, Schilling A, Peterson BA, Greenberg D, Holland JC. Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol. 1998 Mar; 9(3):297-306.
View in: PubMed

Canellos GP. Treatment of relapsed Hodgkin's disease: strategies and prognostic factors. Ann Oncol. 1998; 9 Suppl 5:S91-6.
View in: PubMed

Canellos GP. Selection bias in trials of transplantation for metastatic breast cancer: have we picked the apple before it was ripe? J Clin Oncol. 1997 Oct; 15(10):3169-70.
View in: PubMed

Bodis S, Kraus MD, Pinkus G, Silver B, Kadin ME, Canellos GP, Shulman LN, Tarbell NJ, Mauch PM. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. J Clin Oncol. 1997 Sep; 15(9):3060-6.
View in: PubMed

Hughes-Davies L, Tarbell NJ, Coleman CN, Silver B, Shulman LN, Linggood R, Canellos GP, Mauch PM. Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement. Int J Radiat Oncol Biol Phys. 1997 Sep 01; 39(2):361-9.
View in: PubMed

Canellos GP. CHOP may have been part of the beginning but certainly not the end: issues in risk-related therapy of large-cell lymphoma. J Clin Oncol. 1997 May; 15(5):1713-6.
View in: PubMed

Janicek M, Kaplan W, Neuberg D, Canellos GP, Shulman LN, Shipp MA. Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy. J Clin Oncol. 1997 Apr; 15(4):1631-7.
View in: PubMed

Canellos GP. Is CHOP the standard of therapy for poor-prognosis large-cell lymphoma? Ann Oncol. 1997; 8 Suppl 1:61-2.
View in: PubMed

Shaffer K, Smith D, Kirn D, Kaplan W, Canellos G, Mauch P, Shulman LN. Primary mediastinal large-B-cell lymphoma: radiologic findings at presentation. AJR Am J Roentgenol. 1996 Aug; 167(2):425-30.
View in: PubMed

Canellos GP. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD? Leukemia. 1996 Jun; 10 Suppl 2:s68.
View in: PubMed

Perloff M, Norton L, Korzun AH, Wood WC, Carey RW, Gottlieb A, Aust JC, Bank A, Silver RT, Saleh F, Canellos GP, Perry MC, Weiss RB, Holland JF. Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol. 1996 May; 14(5):1589-98.
View in: PubMed

Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood. 1996 May 01; 87(9):3625-32.
View in: PubMed

Canellos GP. Current strategies for early Hodgkin's disease. Ann Oncol. 1996; 7 Suppl 4:91-3.
View in: PubMed

Shipp MA, Neuberg D, Janicek M, Canellos GP, Shulman LN. High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study. J Clin Oncol. 1995 Dec; 13(12):2916-23.
View in: PubMed

Canellos GP, Petroni GR, Barcos M, Duggan DB, Peterson BA. Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B. J Clin Oncol. 1995 Aug; 13(8):2005-11.
View in: PubMed

Mauch PM, Kalish LA, Marcus KC, Shulman LN, Krill E, Tarbell NJ, Silver B, Weinstein H, Come S, Canellos GP, Coleman CN. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am. 1995 May-Jun; 1(1):33-42.
View in: PubMed

Mauch PM, Canellos GP, Shulman LN, Silver B, Tarbell NJ, Come S, Rabin MS, Coleman CN. Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial. J Clin Oncol. 1995 Apr; 13(4):947-52.
View in: PubMed

Marcus KC, Kalish LA, Coleman CN, Shulman LN, Rosenthal DS, Canellos GP, Mauch PM. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy. J Clin Oncol. 1994 Dec; 12(12):2567-72.
View in: PubMed

Canellos GP. ASCO 30 years later: the state of the Society. J Clin Oncol. 1994 Nov; 12(11):2510-3.
View in: PubMed

Haluska FG, Brufsky AM, Canellos GP. The cellular biology of the Reed-Sternberg cell. Blood. 1994 Aug 15; 84(4):1005-19.
View in: PubMed

Matulonis UA, Griffin JD, Canellos GP. Autologous peripheral stem cell transplantation of the blastic phase of chronic myeloid leukemia following sequential high-dose cytosine arabinoside and melphalan. Am J Hematol. 1994 Apr; 45(4):283-7.
View in: PubMed

Canellos GP. High-dose therapy: here to stay or just visiting? J Clin Oncol. 1994 Jan; 12(1):5-6.
View in: PubMed

Canellos GP. Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphoma. Ann Oncol. 1994; 5 Suppl 2:121-2.
View in: PubMed

Ahles TA, Silberfarb PM, Rundle AC, Holland JC, Kornblith AB, Canellos GP, Green MR, Perry MC. Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group B. Psychother Psychosom. 1994; 62(3-4):193-9.
View in: PubMed

Kornblith AB, Hollis DR, Zuckerman E, Lyss AP, Canellos GP, Cooper MR, Herndon JE, Phillips CA, Abrams J, Aisner J, et al. Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. J Clin Oncol. 1993 Nov; 11(11):2081-9.
View in: PubMed

Uematsu M, Tarbell NJ, Silver B, Coleman CN, Rosenthal DS, Shulman LN, Canellos G, Weinstein H, Mauch P. Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy. Cancer. 1993 Jul 01; 72(1):207-12.
View in: PubMed

Kirn D, Mauch P, Shaffer K, Pinkus G, Shipp MA, Kaplan WD, Tung N, Wheeler C, Beard CJ, Canellos GP, et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol. 1993 Jul; 11(7):1336-43.
View in: PubMed

Robertson MJ, Tantravahi R, Griffin JD, Canellos GP, Cannistra SA. Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myelogenous leukemia with continuous infusion of low-dose cytarabine. Am J Hematol. 1993 Jun; 43(2):95-102.
View in: PubMed

Shapiro CL, Gelman RS, Hayes DF, Osteen R, Obando A, Canellos GP, Frei E, Henderson IC. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes. J Natl Cancer Inst. 1993 May 19; 85(10):812-7.
View in: PubMed

Shulman LN, Frisard B, Antin JH, Wheeler C, Pinkus G, Magauran N, Mauch P, Nobles E, Mashal R, Canellos G, et al. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol. 1993 May; 11(5):937-42.
View in: PubMed

Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993 Apr 15; 71(8):2585-97.
View in: PubMed

Healey EA, Tarbell NJ, Kalish LA, Silver B, Rosenthal DS, Marcus K, Shulman LN, Coleman CN, Canellos G, Weinstein H, et al. Prognostic factors for patients with Hodgkin disease in first relapse. Cancer. 1993 Apr 15; 71(8):2613-20.
View in: PubMed

Mir R, Anderson J, Strauchen J, Nissen NI, Cooper MR, Rafla S, Canellos GP, Bloomfield CD, Gottlieb AJ, Peterson B, et al. Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B. Cancer. 1993 Mar 01; 71(5):1857-66.
View in: PubMed

Cooper MR, Dear K, McIntyre OR, Ozer H, Ellerton J, Canellos G, Bernhardt B, Duggan D, Faragher D, Schiffer C. A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study. J Clin Oncol. 1993 Jan; 11(1):155-60.
View in: PubMed

Canellos GP, Demetri GD. Myelosuppression and "conventional" chemotherapy: what price, what benefit? J Clin Oncol. 1993 Jan; 11(1):1-2.
View in: PubMed

Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med. 1992 Nov 19; 327(21):1478-84.
View in: PubMed

Kornblith AB, Anderson J, Cella DF, Tross S, Zuckerman E, Cherin E, Henderson ES, Canellos GP, Kosty MP, Cooper MR, et al. Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD. Cancer. 1992 Nov 15; 70(10):2508-16.
View in: PubMed

Canellos GP. Current therapeutic strategies in Hodgkin's disease. Ann Oncol. 1992 Sep; 3 Suppl 4:67-8.
View in: PubMed

Canellos GP. The second chance for advanced Hodgkin's disease. J Clin Oncol. 1992 Feb; 10(2):175-7.
View in: PubMed

Kantoff PW, Kalish LA, McDowell-Bryant P, Canellos GP, Gibbs R, Richie JP, Garnick MB. Long-term followup of 150 patients with testicular cancer treated at a single institution. J Urol. 1992 Jan; 147(1):82-8.
View in: PubMed

Whippen DA, Canellos GP. Burnout syndrome in the practice of oncology: results of a random survey of 1,000 oncologists. J Clin Oncol. 1991 Oct; 9(10):1916-20.
View in: PubMed

Mashal RD, Canellos GP. Small non-cleaved cell lymphoma in adults. Am J Hematol. 1991 Sep; 38(1):40-7.
View in: PubMed

Shapiro CL, Yeap BY, Godleski J, Jochelson MS, Shipp MA, Skarin AT, Canellos GP. Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens. Cancer. 1991 Aug 15; 68(4):699-705.
View in: PubMed

Tura S, Canellos G, Goldstone A, Longo D, McMillan A, Urba W, Zinzani PL. Hodgkin's disease: controversies and challenges for the future. Haematologica. 1991 Jul-Aug; 76(4):263-79.
View in: PubMed

Weeks JC, Yeap BY, Canellos GP, Shipp MA. Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J Clin Oncol. 1991 Jul; 9(7):1196-203.
View in: PubMed

Canellos GP. Has the MOPP era ended? Br J Cancer. 1991 Apr; 63(4):483.
View in: PubMed

Coiffier B, Shipp MA, Cabanillas F, Crowther D, Armitage JO, Canellos GP. Report of the first workshop on prognostic factors in large-cell lymphomas. Ann Oncol. 1991 Feb; 2 Suppl 2:213-7.
View in: PubMed

Canellos GP. Is there an effective salvage therapy for advanced Hodgkin's disease? Ann Oncol. 1991 Jan; 2 Suppl 1:1-7.
View in: PubMed

Canellos GP, Rosenberg W. Will doxorubicin-containing regimens replace MOPP and its variants? Leukemia. 1991; 5 Suppl 1:50-2.
View in: PubMed

Kaplan WD, Jochelson MS, Herman TS, Nadler LM, Stomper PC, Takvorian T, Andersen JW, Canellos GP. Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol. 1990 Dec; 8(12):1966-70.
View in: PubMed

Canellos GP. Who should pay for clinical research? J Clin Oncol. 1990 Nov; 8(11):1775-6.
View in: PubMed

Henderson IC, Hayes DF, Parker LM, Love S, Garber JE, Recht A, Breitmeyer JB, Harris JR, Canellos GP. Adjuvant systemic therapy for patients with node-negative tumors. Cancer. 1990 May 01; 65(9 Suppl):2132-47.
View in: PubMed

Canellos GP. Clinical characteristics of the blast phase of chronic granulocytic leukemia. Hematol Oncol Clin North Am. 1990 Apr; 4(2):359-67.
View in: PubMed

Mauch P, Larson D, Osteen R, Silver B, Yeap B, Canellos G, Weinstein H, Rosenthal D, Pinkus G, Jochelson M, et al. Prognostic factors for positive surgical staging in patients with Hodgkin's disease. J Clin Oncol. 1990 Feb; 8(2):257-65.
View in: PubMed

Canellos GP. Can MOPP be replaced in the treatment of advanced Hodgkin's disease? Semin Oncol. 1990 Feb; 17(1 Suppl 2):2-6.
View in: PubMed

Shipp MA, Yeap BY, Harrington DP, Klatt MM, Pinkus GS, Jochelson MS, Rosenthal DS, Skarin AT, Canellos GP. The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen. J Clin Oncol. 1990 Jan; 8(1):84-93.
View in: PubMed

Soiffer RJ, Caligiuri MA, Tondini C, Canellos GP. High-dose cytosine arabinoside in relapsed and refractory non-Hodgkin's lymphoma. Limited role as a single agent. Cancer. 1989 Nov 15; 64(10):2014-8.
View in: PubMed

Pedrazzini A, Freedman AS, Andersen J, Heflin L, Anderson K, Takvorian T, Canellos GP, Whitman J, Coral F, Ritz J, et al. Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function. Blood. 1989 Nov 01; 74(6):2203-11.
View in: PubMed

Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989 Nov; 7(11):1630-6.
View in: PubMed

Canellos GP. Recent issues in chemotherapy for Hodgkin's disease. Curr Opin Oncol. 1989 Oct; 1(1):29-31.
View in: PubMed

Leopold KA, Canellos GP, Rosenthal D, Shulman LN, Weinstein H, Mauch P. Stage IA-IIB Hodgkin's disease: staging and treatment of patients with large mediastinal adenopathy. J Clin Oncol. 1989 Aug; 7(8):1059-65.
View in: PubMed

Krag KJ, Canellos GP, Griffiths CT, Knapp RC, Parker LM, Welch WR, Klatt M, Andersen J. Predictive factors for long-term survival in patients with advanced ovarian cancer. Gynecol Oncol. 1989 Jul; 34(1):88-93.
View in: PubMed

Shipp MA, Klatt MM, Yeap B, Jochelson MS, Mauch PM, Rosenthal DS, Skarin AT, Canellos GP. Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy. J Clin Oncol. 1989 May; 7(5):613-8.
View in: PubMed

Druker BJ, Rosenthal DS, Canellos GP. Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease. Cancer. 1989 Mar 15; 63(6):1060-4.
View in: PubMed

Canellos GP. Treatment of chronic granulocytic leukemia in blastic crisis. Bone Marrow Transplant. 1989 Jan; 4 Suppl 1:131-2.
View in: PubMed

Canellos GP. The role of alkylating agents in acute and chronic leukemia. Bone Marrow Transplant. 1989 Jan; 4 Suppl 1:46-7.
View in: PubMed

Ernst TJ, Rosenthal DS, Griffin JD, Canellos GP. Treatment of the blastic phase of chronic myelogenous leukemia with high-dose cytosine arabinoside. Am J Clin Oncol. 1988 Dec; 11(6):623-6.
View in: PubMed

Mauch P, Tarbell N, Weinstein H, Silver B, Goffman T, Osteen R, Zajac A, Coleman CN, Canellos G, Rosenthal D. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol. 1988 Oct; 6(10):1576-83.
View in: PubMed

Canellos GP. The dose dilemma. J Clin Oncol. 1988 Sep; 6(9):1363-4.
View in: PubMed

Mentzer SJ, Osteen RT, Pappas TN, Rosenthal DS, Canellos GP, Wilson RE. Surgical therapy of localized abdominal non-Hodgkin's lymphomas. Surgery. 1988 Jun; 103(6):609-14.
View in: PubMed

Canellos GP. Residual mass in lymphoma may not be residual disease. J Clin Oncol. 1988 Jun; 6(6):931-3.
View in: PubMed

Canellos GP, Nadler L, Takvorian T. Autologous bone marrow transplantation in the treatment of malignant lymphoma and Hodgkin's disease. Semin Hematol. 1988 Apr; 25(2 Suppl 2):58-65.
View in: PubMed

Canellos GP. Systemic therapy of breast cancer. Med J Aust. 1988 Jan 18; 148(2):88-91.
View in: PubMed

Takvorian T, Canellos GP, Ritz J, Freedman AS, Anderson KC, Mauch P, Tarbell N, Coral F, Daley H, Yeap B, et al. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med. 1987 Jun 11; 316(24):1499-505.
View in: PubMed

Canellos GP. The case for high-dose chemotherapy: is it chemotherapy's last gamble? Eur J Cancer Clin Oncol. 1987 Apr; 23(4):351-5.
View in: PubMed

Canellos GP, Skarin AT, Klatt MM, Rosenthal DS, Case DC, Pinkus GS, Jochelson MS, Yeap BY, Shipp MA. The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma. Semin Hematol. 1987 Apr; 24(2 Suppl 1):2-7.
View in: PubMed

Takvorian T, Canellos G. Experimental approaches in the treatment of lymphoma. Baillieres Clin Haematol. 1987 Mar; 1(1):205-21.
View in: PubMed

Henderson IC, Hayes DF, Come S, Harris JR, Canellos G. New agents and new medical treatments for advanced breast cancer. Semin Oncol. 1987 Mar; 14(1):34-64.
View in: PubMed

Anderson KC, Ritz J, Takvorian T, Coral F, Daley H, Gorgone BC, Freedman AS, Canellos GP, Schlossman SF, Nadler LM. Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow. Blood. 1987 Feb; 69(2):597-604.
View in: PubMed

Anderson KC, Nadler LM, Takvorian T, Freedman AS, Canellos GP, Schlossman SF, Ritz J. Monoclonal antibodies: their use in bone marrow transplantation. Prog Hematol. 1987; 15:137-81.
View in: PubMed

Mentzer SJ, Osteen RT, Starnes HF, Moloney WC, Rosenthal D, Canellos G, Wilson RE. Splenic enlargement and hyperfunction as indications for splenectomy in chronic leukemia. Ann Surg. 1987 Jan; 205(1):13-7.
View in: PubMed

Skarin AT, Canellos GP. Methotrexate-leucovorin factor rescue regimens in diffuse large cell lymphoma. NCI Monogr. 1987; (5):71-6.
View in: PubMed

Rybak ME, Anderson JR, Poulin RF, Amrein PC, Canellos GP, Gottlieb AJ. Phase II trial of m-AMSA therapy in refractory Hodgkin's disease and non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 7972. Cancer Treat Rep. 1986 Oct; 70(10):1233-4.
View in: PubMed

Siegel RD, Skarin AT, Canellos GP. Relapse with nodular lymphoma following combination chemotherapy for diffuse non-Hodgkin's lymphoma. Am J Clin Oncol. 1986 Oct; 9(5):420-3.
View in: PubMed

Shipp MA, Harrington DP, Klatt MM, Jochelson MS, Pinkus GS, Marshall JL, Rosenthal DS, Skarin AT, Canellos GP. Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med. 1986 Jun; 104(6):757-65.
View in: PubMed

Canellos GP. Hormonal agents and treatment of cancer. Urology. 1986 Jan; 27(1 Suppl):4-8.
View in: PubMed

Henderson IC, Gelman RS, Harris JR, Canellos GP. Duration of therapy in adjuvant chemotherapy trials. NCI Monogr. 1986; (1):95-8.
View in: PubMed

Sokal JE, Baccarani M, Tura S, Fiacchini M, Cervantes F, Rozman C, Gomez GA, Galton DA, Canellos GP, Braun TJ, et al. Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood. 1985 Dec; 66(6):1352-7.
View in: PubMed

Anderson KC, Kaplan WD, Leonard RC, Skarin AT, Canellos GP. Role of 99mTc methylene diphosphonate bone imaging in the management of lymphoma. Cancer Treat Rep. 1985 Dec; 69(12):1347-51.
View in: PubMed

Canellos GP. Interferon in the treatment of malignant lymphoma. Semin Oncol. 1985 Dec; 12(4 Suppl 5):25-9.
View in: PubMed

Canellos GP. Bone marrow transplantation as salvage therapy in advanced Hodgkin's disease: allogeneic or autologous. J Clin Oncol. 1985 Nov; 3(11):1451-4.
View in: PubMed

Mauch P, Leonard R, Skarin A, Rosenthal D, Come S, Chaffey J, Hellman S, Canellos G. Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. J Clin Oncol. 1985 Oct; 3(10):1301-8.
View in: PubMed

Canellos GP, Griffin JD. Chronic granulocytic leukemia: the heterogeneity of stem cell differentiation within a single disease entity. Semin Oncol. 1985 Sep; 12(3):281-8.
View in: PubMed

Mauch P, Goffman T, Rosenthal DS, Canellos GP, Come SE, Hellman S. Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone. J Clin Oncol. 1985 Sep; 3(9):1166-73.
View in: PubMed

Budman DR, Anderson J, Obrecht JP, Canellos GP, Creaven P, Norton L, Gottlieb A. Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone: cancer and leukemia group B trial 8171. Cancer Treat Rep. 1985 Jun; 69(6):719-20.
View in: PubMed

Jochelson M, Mauch P, Balikian J, Rosenthal D, Canellos G. The significance of the residual mediastinal mass in treated Hodgkin's disease. J Clin Oncol. 1985 May; 3(5):637-40.
View in: PubMed

Mauch PM, Canellos GP, Rosenthal DS, Hellman S. Reduction of fatal complications from combined modality therapy in Hodgkin's disease. J Clin Oncol. 1985 Apr; 3(4):501-5.
View in: PubMed

Loeffler JS, Ervin TJ, Mauch P, Skarin A, Weinstein HJ, Canellos G, Cassady JR. Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol. 1985 Apr; 3(4):490-4.
View in: PubMed

Karp DD, Parker LM, Binder N, Tantravahi R, Smith BR, Ervin TJ, Canellos GP. Treatment of the blastic transformation of chronic granulocytic leukemia using high dose BCNU chemotherapy and cryopreserved autologous peripheral blood stem cells. Am J Hematol. 1985 Mar; 18(3):243-9.
View in: PubMed

Antman K, Pomfret E, Karp G, Skarin A, Canellos G. Phase II trial of etoposide in previously treated small cell carcinoma of the lung. Cancer Treat Rep. 1984 Nov; 68(11):1413-4.
View in: PubMed

Anderson KC, Skarin AT, Rosenthal DS, MacIntyre JM, Pinkus GS, Case DC, Leonard RC, Canellos GP. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies. Cancer Treat Rep. 1984 Nov; 68(11):1343-50.
View in: PubMed

Shipp MA, Takvorian RC, Canellos GP. High-dose cytosine arabinoside. Active agent in treatment of non-Hodgkin's lymphoma. Am J Med. 1984 Nov; 77(5):845-50.
View in: PubMed

Stahel RA, Takvorian RW, Skarin AT, Canellos GP. Autologous bone marrow transplantation following high-dose chemotherapy with cyclophosphamide, BCNU and VP-16 in small cell carcinoma of the lung and a review of current literature. Eur J Cancer Clin Oncol. 1984 Oct; 20(10):1233-8.
View in: PubMed

Canellos GP. Therapy-related leukemia: a necessary complication of successful systemic chemotherapy? J Clin Oncol. 1984 Oct; 2(10):1077-9.
View in: PubMed

Nadler LM, Takvorian T, Botnick L, Bast RC, Finberg R, Hellman S, Canellos GP, Schlossman SF. Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet. 1984 Aug 25; 2(8400):427-31.
View in: PubMed

Canellos GP. The treatment of locally advanced breast cancer. J Clin Oncol. 1984 Mar; 2(3):149-51.
View in: PubMed

Lederman GS, Garnick MB, Canellos GP, Richie JP. Chemotherapy of refractory germ cell cancer with Etoposide. J Clin Oncol. 1983 Nov; 1(11):706-9.
View in: PubMed

Garnick MB, Canellos GP, Richie JP. Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA. 1983 Oct 07; 250(13):1733-41.
View in: PubMed

Takvorian T, Parker LM, Hochberg FH, Canellos GP. Autologous bone-marrow transplantation: host effects of high-dose BCNU. J Clin Oncol. 1983 Oct; 1(10):610-20.
View in: PubMed

Neumann CH, Robert NJ, Canellos G, Rosenthal D. Computed tomography of the abdomen and pelvis in non-Hodgkin lymphoma. J Comput Assist Tomogr. 1983 Oct; 7(5):846-50.
View in: PubMed

Lipton JM, Nadler LM, Canellos GP, Kudisch M, Reiss CS, Nathan DG. Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man. J Clin Invest. 1983 Aug; 72(2):694-706.
View in: PubMed

Neumann CH, Robert NJ, Rosenthal D, Canellos G. Clinical value of ultrasonography for the management of non-Hodgkin lymphoma patients as compared with abdominal computed tomography. J Comput Assist Tomogr. 1983 Aug; 7(4):666-9.
View in: PubMed

Anderson KC, Leonard RC, Canellos GP, Skarin AT, Kaplan WD. High-dose gallium imaging in lymphoma. Am J Med. 1983 Aug; 75(2):327-31.
View in: PubMed

Anderson KC, Garnick MB, Meshad MW, Cohen GI, Pegg WJ, Frei E, Israel M, Modest E, Canellos GP. Phase I trial of mitoxantrone by 24-hour continuous infusion. Cancer Treat Rep. 1983 May; 67(5):435-8.
View in: PubMed

Bauer KA, Skarin AT, Balikian JP, Garnick MB, Rosenthal DS, Canellos GP. Pulmonary complications associated with combination chemotherapy programs containing bleomycin. Am J Med. 1983 Apr; 74(4):557-63.
View in: PubMed

Griffin JD, Tantravahi R, Canellos GP, Wisch JS, Reinherz EL, Sherwood G, Beveridge RP, Daley JF, Lane H, Schlossman SF. T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia. Blood. 1983 Apr; 61(4):640-4.
View in: PubMed

Skarin AT, Canellos GP, Rosenthal DS, Case DC, MacIntyre JM, Pinkus GS, Moloney WC, Frei E. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol. 1983 Feb; 1(2):91-8.
View in: PubMed

Antman KH, Blum RH, Wilson RE, Corson JM, Greenberger JS, Amato DA, Canellos GP, Frei E. Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study. Cancer. 1983 Feb 01; 51(3):396-401.
View in: PubMed

Griffin JD, Todd RF, Ritz J, Nadler LM, Canellos GP, Rosenthal D, Gallivan M, Beveridge RP, Weinstein H, Karp D, Schlossman SF. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood. 1983 Jan; 61(1):85-91.
View in: PubMed

Canellos GP, Come SE, Skarin AT. Chemotherapy in the treatment of Hodgkin's disease. Semin Hematol. 1983 Jan; 20(1):1-24.
View in: PubMed

Anderson T, DeVita VT, Simon RM, Berard CW, Canellos GP, Garvin AJ, Young RC. Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer Institute. Cancer. 1982 Dec 15; 50(12):2708-21.
View in: PubMed

Balikian JP, Jochelson MS, Bauer KA, Skarkin AT, Garnick MB, Canellos GP, Smith EH. Pulmonary complications of chemotherapy regimens containing bleomycin. AJR Am J Roentgenol. 1982 Sep; 139(3):455-61.
View in: PubMed

Todd RF, Garnick MB, Canellos GP. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma. Cancer Treat Rep. 1982 Jul; 66(7):1585-6.
View in: PubMed

Canellos GP, Hellman S, Veronesi U. Occasional notes. The management of early breast cancer. N Engl J Med. 1982 Jun 10; 306(23):1430-2.
View in: PubMed

Cunningham J, Mauch P, Rosenthal DS, Canellos GP. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease. Cancer Treat Rep. 1982 Apr; 66(4):1015-22.
View in: PubMed

Hubbard SM, Chabner BA, DeVita VT, Simon R, Berard CW, Jones RB, Garvin AJ, Canellos GP, Osborne CK, Young RC. Histologic progression in non-Hodgkin's lymphoma. Blood. 1982 Feb; 59(2):258-64.
View in: PubMed

Cohen GI, Greenberger JS, Canellos GP. Effect of chemotherapy and irradiation on interactions between stromal and hemopoietic cells in vitro. Scan Electron Microsc. 1982; (Pt 1):359-65.
View in: PubMed

Kirkwood JM, Canellos GP, Ervin TJ, Pitman SW, Weichselbaum R, Miller D. Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen. Cancer. 1981 May 15; 47(10):2414-21.
View in: PubMed

Hochberg FH, Parker LM, Takvorian T, Canellos GP, Zervas NT. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg. 1981 Apr; 54(4):455-60.
View in: PubMed

Henderson IC, Gelman R, Canellos GP, Frei E. Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue. Cancer Treat Rep. 1981; 65 Suppl 1:67-75.
View in: PubMed

Abelson HT, Kufe DW, Skarin AT, Major P, Ensminger W, Beardsley GP, Canellos GP. Treatment of central nervous system tumors with methotrexate. Cancer Treat Rep. 1981; 65 Suppl 1:137-40.
View in: PubMed

Canellos GP, Skarin AT, Rosenthal DS, Moloney WC, Frei E. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology. Cancer Treat Rep. 1981; 65 Suppl 1:125-9.
View in: PubMed

Todd RF, Garnick MB, Canellos GP, Richie JP, Gittes RF, Mayer RJ, Skarin AT. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma. Cancer Treat Rep. 1981 Jan-Feb; 65(1-2):17-20.
View in: PubMed

Li FP, Corkery J, Canellos G, Neitlich HW. Breast cancer after Hodgkin's disease in two sisters. Cancer. 1981 Jan 01; 47(1):200-2.
View in: PubMed

Karp G, Antman K, Canellos G. VP-16-213. A phase II trial using a weekly schedule. Cancer Clin Trials. 1981; 4(4):465-7.
View in: PubMed

Lampidis TJ, Henderson IC, Israel M, Canellos GP. Structural and functional effects of adriamycin on cardiac cells in vitro. Cancer Res. 1980 Nov; 40(11):3901-9.
View in: PubMed

Blum RH, Corson JM, Wilson RE, Greenberger JS, Canellos GP, Frei E. Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD). Cancer. 1980 Oct 15; 46(8):1722-6.
View in: PubMed

Pesando JM, Come SE, Stark J, Parker LM, Griffiths CT, Canellos GP. cis-Diamminedichloroplatinum(II) therapy for advanced ovarian cancer. Cancer Treat Rep. 1980 Oct-Nov; 64(10-11):1147-8.
View in: PubMed

Frei E, Canellos GP. Dose: a critical factor in cancer chemotherapy. Am J Med. 1980 Oct; 69(4):585-94.
View in: PubMed

Ervin TJ, Blum RH, Meshad MW, Kufe DW, Johnson RK, Canellos GP. Phase I trial of N-(Phosphonacetyl)-L-aspartic acid (PALA). Cancer Treat Rep. 1980 Oct-Nov; 64(10-11):1067-71.
View in: PubMed

Parker LM, Griffiths CT, Yankee RA, Canellos GP, Gelman R, Knapp RC, Richman CM, Tobias JS, Weiner RS, Frei E. Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer. 1980 Aug 15; 46(4):669-74.
View in: PubMed

DeVita VT, Simon RM, Hubbard SM, Young RC, Berard CW, Moxley JH, Frei E, Carbone PP, Canellos GP. Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med. 1980 May; 92(5):587-95.
View in: PubMed

Ervin T, Canellos GP. Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate. Cancer. 1980 Apr 01; 45(7):1556-7.
View in: PubMed

Kufe DW, Beardsley P, Karp D, Parker L, Rosowsky A, Canellos G, Frei E. High-dose thymidine infusions in patients with leukemia and lymphoma. Blood. 1980 Apr; 55(4):580-9.
View in: PubMed

Frei E, Blum RH, Pitman SW, Kirkwood JM, Henderson IC, Skarin AT, Mayer RJ, Bast RC, Garnick MB, Parker LM, Canellos GP. High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. Am J Med. 1980 Mar; 68(3):370-6.
View in: PubMed

Antman KH, Blum RH, Greenberger JS, Flowerdew G, Skarin AT, Canellos GP. Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med. 1980 Mar; 68(3):356-62.
View in: PubMed

Henderson IC, Canellos GP. Cancer of the breast: the past decade (second of two parts). N Engl J Med. 1980 Jan 10; 302(2):78-90.
View in: PubMed

Henderson IC, Canellos GP. Cancer of the breast: the past decade (first of two parts). N Engl J Med. 1980 Jan 03; 302(1):17-30.
View in: PubMed

Garnick MB, Blum RH, Canellos GP, Mayer RJ, Parker L, Skarin AT, Li FP, Henderson IC, Frei E. Phase I trial of bruceantin. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):1929-32.
View in: PubMed

Griffin TW, Lister TA, Rybak ME, Rosenthal DS, Canellos GP, Woodruff R, Oliver KT. Treatment of acute nonlymphocytic leukemia with neocarzinostatin. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):1853-6.
View in: PubMed

Skarin AT, Canellos GP. Chemotherapy of advanced non-Hodgkin's lymphoma. Clin Haematol. 1979 Oct; 8(3):667-84.
View in: PubMed

Antman KH, Skarin AT, Mayer RJ, Hargreaves HK, Canellos GP. Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore). 1979 Sep; 58(5):377-84.
View in: PubMed

Garnick MB, Canellos GP, Richie JP, Stark JJ. Sequential combination chemotherapy and surgery for disseminated testicular cancer: cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin remission-induction therapy followed by cyclophosphamide and adriamycin. Cancer Treat Rep. 1979 Sep-Oct; 63(9-10):1681-6.
View in: PubMed

Blum RH, Garnick MB, Israel M, Canellos GP, Henderson IC, Frei E. Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog. Cancer Treat Rep. 1979 May; 63(5):919-23.
View in: PubMed

Canellos GP, Sutliffe SB, DeVita VT, Lister TA. Treatment of refractory splenomegaly in myeloproliferative disease by splenic artery infusion. Blood. 1979 May; 53(5):1014-7.
View in: PubMed

Canellos GP. Reconstitution or resurrection of normal stem cells in chronic granulocytic leukemia. N Engl J Med. 1979 Feb 15; 300(7):360-1.
View in: PubMed

Parker LM, Griffiths CT, Yankee RA, Knapp RC, Canellos GP. High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study. Cancer Treat Rep. 1979 Feb; 63(2):275-9.
View in: PubMed

Young RC, Chabner BA, Hubbard SP, Fisher RI, Bender RA, Anderson T, Simon RM, Canellos GP, DeVita VT. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med. 1978 Dec 07; 299(23):1261-6.
View in: PubMed

Griffin TW, Comis RL, Lokich JJ, Blum RH, Canellos GP. Phase I and preliminary phase II study of neocarzinostatin. Cancer Treat Rep. 1978 Dec; 62(12):2019-25.
View in: PubMed

Young RC, Canellos GP, Chabner BA, Hubbard SM, DeVita VT. Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy. Cancer. 1978 Aug; 42(2 Suppl):1001-7.
View in: PubMed

Canellos GP, Lister TA, Skarin AT. Chemotherapy of the non-Hodgkin's lymphomas. Cancer. 1978 Aug; 42(2 Suppl):932-40.
View in: PubMed

Chabner BA, Johnson RE, Young RC, Canellos GP, Hubbard SP, Johnson SK, DeVita VT. Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma. Cancer. 1978 Aug; 42(2 Suppl):922-5.
View in: PubMed

Canellos GP, Lister TA. The staging and treatment of non-Hodgkin's lymphoma. Br J Haematol. 1978 Aug; 39(4):477-82.
View in: PubMed

Canellos GP. Oncologic emergencies. Semin Oncol. 1978 Jun; 5(2):225-7.
View in: PubMed

Johnson RE, Canellos GP, Young RC, Chabner BA, DeVita VT. Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma. Cancer Treat Rep. 1978 Mar; 62(3):321-5.
View in: PubMed

Canellos GP. Diagnosis and treatment of Hodgkin's disease. Med Times. 1978 Mar; 106(3):30-5.
View in: PubMed

Canellos GP. Treatment of the leukemias. Med Times. 1978 Mar; 106(3):42-5, 49.
View in: PubMed

Canellos GP. Treatment of the non-Hodgkin's lymphomas. Med Times. 1978 Mar; 106(3):37-41.
View in: PubMed

Blum RH, Wittenberg BK, Canellos GP, Mayer RJ, Skarin AT, Henderson IC, Parker LM, Frei E. A therapeutic trial of maytansine. Cancer Clin Trials. 1978; 1(2):113-7.
View in: PubMed

Skarin AT, Zuckerman KS, Pitman SW, Rosenthal DS, Moloney W, Frei E, Canellos GP. High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement. Blood. 1977 Dec; 50(6):1039-47.
View in: PubMed

Rosenthal S, Canellos GP, Whang-Peng J, Gralnick HR. Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. Am J Med. 1977 Oct; 63(4):542-7.
View in: PubMed

Band PR, Canellos GP, Sears M, Israel L, Pocock SJ. Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast. Cancer Treat Rep. 1977 Oct; 61(7):1365-7.
View in: PubMed

Arseneau JC, Canellos GP, Johnson R, DeVita VT. Risk of new cancers in patients with Hodgkin's disease. Cancer. 1977 Oct; 40(4 Suppl):1912-6.
View in: PubMed

Chabner BA, Johnson RE, DeVita VT, Canellos GP, Hubbard SP, Johnson SK, Young RC. Sequential staging in non-Hodgkin's lymphoma. Cancer Treat Rep. 1977 Sep; 61(6):993-7.
View in: PubMed

Young RC, Johnson RE, Canellos GP, Chabner BA, Brereton HD, Berard CW, DeVita VT. Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination. Cancer Treat Rep. 1977 Sep; 61(6):1153-9.
View in: PubMed

Rosenthal S, Schwartz JH, Canellos GP. Basophilic chronic granulocytic leukaemia with hyperhistaminaemia. Br J Haematol. 1977 Jul; 36(3):367-72.
View in: PubMed

Rosenthal S, Canellos GP, DeVita VT, Gralnick HR. Characteristics of blast crisis in chronic granulocytic leukemia. Blood. 1977 May; 49(5):705-14.
View in: PubMed

Hellman S, Chaffey JT, Rosenthal DS, Moloney WC, Canellos GP, Skarin AT. The place of radiation therapy in the treatment of non-Hodgkin's lymphomas. Cancer. 1977 Feb; 39(2 Suppl):843-51.
View in: PubMed

Canellos GP. The treatment of chronic granulocytic leukaemia. Clin Haematol. 1977 Feb; 6(1):113-28.
View in: PubMed

Canellos GP, Pocock SJ, Taylor SG, Sears ME, Klaasen DJ, Band PR. Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard. Cancer. 1976 Nov; 38(5):1882-6.
View in: PubMed

Schein PS, DeVita VT, Hubbard S, Chabner BA, Canellos GP, Berard C, Young RC. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med. 1976 Oct; 85(4):417-22.
View in: PubMed

Canellos GP. Chronic granulocytic leukemia. Med Clin North Am. 1976 Sep; 60(5):1001-18.
View in: PubMed

Chabner BA, Johnson RE, Young RC, Canellos GP, Hubbard SP, Johnson SK, DeVita VT. Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma. Ann Intern Med. 1976 Aug; 85(2):149-54.
View in: PubMed

Jacobs A, Slater A, Whittaker JA, Canellos G, Wiernik PH. Serum ferritin concentration in untreated Hodgkin's disease. Br J Cancer. 1976 Aug; 34(2):162-6.
View in: PubMed

Woolley PV, Osborne CK, Levi JA, Wiernik PH, Canellos GP. Extranodal presentation of non-Hodgkin's lymphomas in the testis. Cancer. 1976 Aug; 38(2):1026-35.
View in: PubMed

Canellos GP, DeVita VT, Whang-Peng J, Chabner BA, Schein PS, Young RC. Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy. Blood. 1976 Jun; 47(6):1003-9.
View in: PubMed

Canellos GP, Whang-Peng J, DeVita VT. Chronic granulocytic leukemia without the Philadelphia chromosome. Am J Clin Pathol. 1976 Apr; 65(4):467-70.
View in: PubMed

Canellos GP, DeVita VT, Gold GL, Chabner BA, Schein PS, Young RC. Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Intern Med. 1976 Apr; 84(4):389-92.
View in: PubMed

Ihde DC, DeVita VT, Canellos GP, Young RC. Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. Blood. 1976 Feb; 47(2):211-22.
View in: PubMed

Ihde DC, Canellos GP, Schwartz JH, DeVita VT. Splenectomy in the chronic phase of chronic granulocytic leukemia. Effects in 32 patients. Ann Intern Med. 1976 Jan; 84(1):17-21.
View in: PubMed

Schwartz JH, Canellos GP, Young RC, DeVita VT. Meningeal leukemia in the blastic phase of chronic granulocytic leukemia. Am J Med. 1975 Dec; 59(6):819-28.
View in: PubMed

Young RC, Chabner BA, Hubbard SP, Canellos GP, DeVita VT. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma. Natl Cancer Inst Monogr. 1975 Oct; 42:145-8.
View in: PubMed

Hubbard SP, Chabner BA, Canellos GP, Young RC, DeVita VT. High dose intravenous bleomycin in the treatment of advanced lymphomas. Eur J Cancer. 1975 Sep; 11(9):623-6.
View in: PubMed

Canellos GP. Editorial: Combination chemotherapy for breast cancer. Cancer Chemother Rep. 1975 Sep-Oct; 59(5):893-4.
View in: PubMed

Canellos GP. Letter: second malignancies complicating Hodgkin's disease in remission. Lancet. 1975 Jun 07; 1(7919):1294.
View in: PubMed

Adamson RH, Canellos GP, Sieber SM. Studies on the antitumor activity of gallium nitrate (NSC-15200) and other group IIIa metal salts. Cancer Chemother Rep. 1975 May-Jun; 59(3):599-610.
View in: PubMed

Canellos GP, Arseneau JC, DeVita VT, Whang-Peng J, Johnson RE. Second malignancies complicating Hodgkin's disease in remission. Lancet. 1975 Apr 26; 1(7913):947-9.
View in: PubMed

Arseneau JC, Canellos GP, Banks PM, Berard CW, Gralnick HR, DeVita VT. American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. Am J Med. 1975 Mar; 58(3):314-21.
View in: PubMed

Canellos GP, DeVita VT, Young RC, Chabner BA, Schein PS, Johnson RE. Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. Br J Cancer Suppl. 1975 Mar; 2:474-80.
View in: PubMed

Schein PS, Chabner BA, Canellos GP, Young RD, Berard C, DeVita VT. Results of combination chemotherapy of non-Hodgkin's lymphoma. Br J Cancer Suppl. 1975 Mar; 2:465-73.
View in: PubMed

Banks PM, Arseneau JC, Gralnick HR, Canellos GP, DeVita VT, Berard CW. American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med. 1975 Mar; 58(3):322-9.
View in: PubMed

Schein PS, Chabner BA, Canellos GP, Young RC, DeVita VT. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy. Cancer. 1975 Feb; 35(2):354-7.
View in: PubMed

DeVita VT, Canellos GP, Chabner B, Schein P, Hubbard SP, Young RC. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet. 1975 Feb 01; 1(7901):248-50.
View in: PubMed

Canellos GP, Young RC, Neiman PE, DeVita VT. Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan. Blood. 1975 Feb; 45(2):197-203.
View in: PubMed

Canellos GP, DeVita VT, Gold GL, Chabner BA, Schein PS, Young RC. Letter: Combination chemotherapy for breast cancer. Br Med J. 1975 Jan 04; 1(5948):37.
View in: PubMed

DeVita VT, Young RC, Canellos GP. Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer. 1975 Jan; 35(1):98-110.
View in: PubMed

Young RC, Canellos GP, Chabner BA, Schein PS, Hubbard SP, DeVita VT. Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamide. Gynecol Oncol. 1974 Dec; 2(4):489-97.
View in: PubMed

Mason JE, DeVita VT, Canellos GP. Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance. Blood. 1974 Oct; 44(4):483-7.
View in: PubMed

Sponzo RW, Arseneau JC, Canellos GP. Procabazine induced oxidative haemolysis: relationship in vivo red cell survival. Br J Haematol. 1974 Aug; 27(4):587-95.
View in: PubMed

Costa JC, Rabson AS, Tralka TS, Engel WK, Canellos GP, Bratenahl CG. Letter: Leukaemia and lower-motor-neuron disease. Lancet. 1974 Jul 13; 2(7872):107-8.
View in: PubMed

Rosenoff SH, Canellos GP, O'Connell M, Wiernik PH. Mediastinal adenopathy in granulocytic leukemia. Arch Intern Med. 1974 Jul; 134(1):135-8.
View in: PubMed

Young RC, Canellos GP, Chabner BA, Schein PS, Brereton HD, DeVita VT. Treatment of malignant melanoma with methyl CCNU. Clin Pharmacol Ther. 1974 Jun; 15(6):617-22.
View in: PubMed

Gelrud LG, Arseneau JC, Milder MS, Kramer RJ, Swann SJ, Canellos GP, Johnston GS. The kinetics of 67gallium incorporation into inflammatory lesions: experimental and clinical studies. J Lab Clin Med. 1974 Mar; 83(3):489-95.
View in: PubMed

Arseneau JC, Aamodt R, Johnston GS, Canellos GP. Evidence for granulocytic incorporation of 67gallium in chronic granulocytic leukemia. J Lab Clin Med. 1974 Mar; 83(3):496-503.
View in: PubMed

Canellos GP, Devita VT, Gold GL, Chabner BA, Schein PS, Young RC. Cyclical combination chemotherapy for advanced breast carcinoma. Br Med J. 1974 Feb 09; 1(5901):218-20.
View in: PubMed

Schein PS, Chabner BA, Canellos GP, Young RC, Berard C, DeVita VT. Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma. Blood. 1974 Feb; 43(2):181-9.
View in: PubMed

Canellos GP. Hypercalcemia in malignant lymphoma and leukemia. Ann N Y Acad Sci. 1974; 230:240-6.
View in: PubMed

Arseneau JC, Canellos GP, DeVita VT, Sherins RJ. Recently recognized complications of cancer chemotherapy. Ann N Y Acad Sci. 1974; 230:481-8.
View in: PubMed

Chabner BA, Sponzo R, Hubbard S, Canellos GP, Young RC, Schein PS, Devita VT. High-dose intermittent intravenous infusion of procarbazine (NSC-77213). Cancer Chemother Rep. 1973 Sep-Oct; 57(3):361-3.
View in: PubMed

Young RC, Canellos GP, Chabner BA, Schein PS, DeVita VT. Maintenance chemotherapy for advanced Hodgkin's disease in remission. Lancet. 1973 Jun 16; 1(7816):1339-43.
View in: PubMed

Young RC, Walker MD, Canellos GP, Schein PS, Chabner BA, DeVita VT. Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU). Cancer. 1973 May; 31(5):1164-9.
View in: PubMed

DeVita VT, Arseneau JC, Sherins RJ, Canellos GP, Young RC. Intensive chemotherapy for Hodgkin's disease: long-term complications. Natl Cancer Inst Monogr. 1973 May; 36:447-54.
View in: PubMed

Canellos GP, Young RC, Berard CW, DeVita VT. Combination chemotherapy and survival in advanced Hodgkin's disease. Arch Intern Med. 1973 Mar; 131(3):388-90.
View in: PubMed

Arseneau JC, Bagley CM, Anderson T, Canellos GP. Hyperkalaemia, a sequel to chemotherapy of Burkitt's lymphoma. Lancet. 1973 Jan 06; 1(7793):10-4.
View in: PubMed

Canellos GP, Whang-Peng J. Philadelphia-chromosome-positive preleukaemic state. Lancet. 1972 Dec 09; 2(7789):1227-8.
View in: PubMed

DeVita VT, Canellos GP, Moxley JH. A decade of combination chemotherapy of advanced Hodgkin's disease. Cancer. 1972 Dec; 30(6):1495-504.
View in: PubMed

Arseneau JC, Sponzo RW, Levin DL, Schnipper LE, Bonner H, Young RC, Canellos GP, Johnson RE, DeVita VT. Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. N Engl J Med. 1972 Nov 30; 287(22):1119-22.
View in: PubMed

Bagley CM, Young RC, Canellos GP, DeVita VT. Treatment of ovarian carcinoma: possibilities for progress. N Engl J Med. 1972 Oct 26; 287(17):856-62.
View in: PubMed

Haskell CM, Canellos GP, Cooney DA, Hardesty CT. Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229). Cancer Chemother Rep. 1972 Oct; 56(5):611-4.
View in: PubMed

Chabner BA, Canellos GP, Olweny CL, DeVita VT. Late recurrence of testicular tumor. N Engl J Med. 1972 Aug 24; 287(8):413.
View in: PubMed

Canellos GP, Whang-Peng J, Schnipper L, Brown CH. Prolonged cytogenetic and hematologic remission of blastic transformation in chronic granulocytic leukemia. Cancer. 1972 Jul; 30(1):288-93.
View in: PubMed

Bagley CM, Canellos GP, Young RC, Gallelli JF, Devita VT. Clinical trials with 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) given intravenously. Cancer Chemother Rep. 1972 Jun; 56(3):387-91.
View in: PubMed

DeVita VT, Canellos GP. Treatment of the lymphomas. Semin Hematol. 1972 Apr; 9(2):193-209.
View in: PubMed

Canellos GP, Nordland J, Carbone PP. Splenectomy for thrombocytopenia in chronic granulocytic leukemia. Cancer. 1972 Mar; 29(3):660-5.
View in: PubMed

Bagley CM, Devita VT, Berard CW, Canellos GP. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med. 1972 Feb; 76(2):227-34.
View in: PubMed

De Vita VT, Canellos GP, Schein PJ, Chabner BA, Bagley CM, Young RC. Proceedings: Malignant lymphoma: treatment with combination chemotherapy. Proc Natl Cancer Conf. 1972; 7:379-90.
View in: PubMed

Canellos GP, De Vita VT, Schein P, Chabner B, Young RC. Proceedings: The chronic leukemias: current therapeutic concepts. Proc Natl Cancer Conf. 1972; 7:351-7.
View in: PubMed

Canellos GP, DeVita VT, Whang-Peng J, Carbone PP. Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. Blood. 1971 Dec; 38(6):671-9.
View in: PubMed

Hakami N, Neiman PE, Canellos GP, Lazerson J. Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. N Engl J Med. 1971 Nov 18; 285(21):1163-70.
View in: PubMed

Young RC, DeVita VT, Serpick AA, Canellos GP. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU. N Engl J Med. 1971 Aug 26; 285(9):475-9.
View in: PubMed

Primack A, Wilson J, O'Connor GT, Engelman K, Hull E, Canellos GP. Hepatocellular carcinoma with the carcinoid syndrome. Cancer. 1971 May; 27(5):1182-9.
View in: PubMed

Haskell CM, DeVita VT, Canellos GP. Hypercalcemia in chronic granulocytic leukemia. Cancer. 1971 Apr; 27(4):872-80.
View in: PubMed

Brown CH, Canellos GP, Carbone PP. Effect of L-asparaginase on mouse bone marrow, assayed by in vitro culture. Blood. 1970 Sep; 36(3):385-9.
View in: PubMed

Haskell CM, Canellos GP, Cooney DA, Hansen HH. Biocmical and pharmacologic effects of L-asparaginase in man. J Lab Clin Med. 1970 May; 75(5):763-70.
View in: PubMed

Haskell CM, Canellos GP. Asparagine biosynthesis in human KB tumor cells: inhibitor studies with asparagine and glutamine antagonists. Cancer Res. 1970 Apr; 30(4):1081-3.
View in: PubMed

Canellos GP, Brain MC, Dacie JV. Effects of sulphydryl inhibition on the erythrocyte in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1970 Mar; 18(3):269-77.
View in: PubMed

Canellos GP, Haskell CM. Studies of resistance to L-asparaginase in human leukemia. Recent Results Cancer Res. 1970; 33:188-93.
View in: PubMed

Hansen HH, Canellos GP. L-asparaginase treatment of acute myeloblastic leukemia. Oncology. 1970; 24(5):349-57.
View in: PubMed

Haskell CM, Canellos GP, Leventhal BG, Carbone PP, Block JB, Serpick AA, Selawry OS. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med. 1969 Nov 06; 281(19):1028-34.
View in: PubMed

Haskell CM, Canellos GP. l-asparaginase resistance in human leukemia--asparagine synthetase. Biochem Pharmacol. 1969 Oct; 18(10):2578-80.
View in: PubMed

Podos SM, Canellos GP. Lens changes in chronic granulocytic leukemia. Possible relationship to chemotherapy. Am J Ophthalmol. 1969 Sep; 68(3):500-4.
View in: PubMed

Chabner BA, Haskell CM, Canellos GP. Destructive bone lesions in chronic granulocytic leukemia. Medicine (Baltimore). 1969 Sep; 48(5):401-10.
View in: PubMed

Canellos GP, Carbone PP, Ziegler ZI. L-asparaginase and Burkitt's lymphoma. Lancet. 1969 Aug 16; 2(7616):380.
View in: PubMed

Haskell CM, Canellos GP, Leventhal BG, Carbone PP, Serpick AA, Hansen HH. L-asparaginase toxicity. Cancer Res. 1969 Apr; 29(4):974-5.
View in: PubMed

Haskell CM, Canellos GP. Asparaginase and leukaemia. Lancet. 1969 Mar 22; 1(7595):626.
View in: PubMed

Canellos GP, Haskell CM, Arseneau J, Carbone PP. Hypoalbuminemic and hypocholesterolemic effect of L-asparaginase (NSC-109,229) treatment in man--a preliminary report. Cancer Chemother Rep. 1969 Feb; 53(1):67-9.
View in: PubMed

Whang-Peng J, Canellos GP, Carbone PP, Tjio JH. Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood. 1968 Nov; 32(5):755-66.
View in: PubMed

Canellos GP, Mead JA, Greenberg NH, Schrecker AW. The effect of treatment with cytotoxic agents on mouse spleen dihydrofolate reductase activity. Cancer Res. 1967 Apr; 27(4):784-8.
View in: PubMed

De Vita VT, Canellos GP. Hypoglycorrhachia in meningeal carcinomatosis. Cancer. 1966 May; 19(5):691-4.
View in: PubMed

LEES RS, CANELLOS GP, ROSENBERG IH, HATCH FT. Myocardial infarction in one of a pair of twenty-seven year old identical male twins. Am J Med. 1963 May; 34:741-6.
View in: PubMed

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Dana 1B14
Boston MA, 02215
Get Directions

Top